The biotech field is crowded with all sorts of confusing jargon and acronyms, so you might be wondering – what exactly is a Collaborative Research Organization (a CRO) and how can it help my startup? And how is this different from a Contract Research Organization (also a CRO, and not to be confused with a Clinical Research Organization—also, also a CRO!). In this blog post, we break down the ins and outs of a Collaborative Research Organization and why your organization needs one to turn its drug development goals into a reality.   

1. Simplify, simplify, simplify

Our experienced team wears many hats – from consultants to project managers – enabling your organization to use just one organization for the majority of its drug development needs.

As a first step, we help your team create a cohesive story. You may ask “A story!? But why? This is a science project, right!?”. Well, we live in a competitive world and you’re most likely not the only ones developing new therapies in this space. Do you know how you’re different, how you’re better, and which experiments best demonstrate this? Can you clearly explain why someone should invest in you or buy your new therapy?

Key element of a good story is a strategic drug development plan.  We love starting all our projects with a plan. We work with you to clearly identify value-inflection experiments that will convince potential investors of the Why behind your preclinical drug idea and how it will impact people’s lives for the better.

From there, we coordinate and execute those preclinical experiments through our vast network of specialized labs. Throughout the entire process, we become an extension of your team, providing integrated project management to streamline your preclinical drug development process from start to finish.

2. Taking the lead

A typical Contract Research Organization is hired by a biotech company to do very defined preclinical or clinical testing and to complete other explicitly directed tasks.

But what if you don’t quite know what’s the right test you need to do next?

A Collaborative Research Organization like Radyus Research guides your team throughout the entire drug development process, so you know exactly what’s coming, and why. We work with you to suggest and implement experiments for optimal preclinical development, from start to finish. To IND approval that is.

At Radyus, we collaborate, contribute and consult—we don’t just contract. Simply put, we bring the collective breadth of our experiences to help you progress your emerging new therapy through the development pathway in a manner that will differentiate you from the pack. And help you attract investors, satisfy the regulators, and line up potential pharma collaborators.

We understand that your unique programs are complex and consequently need a dedicated team to get you from where you are now all the way to exit, whether that’s selling the product or your entire company.

That’s why we are a Collaborative Research Organization. So… you work with only one CRO and get all your needs met under one roof: Project management, scientific and clinical advisory, strategic market assessment, CMC, regulatory, IND enabling studies, and even fundraising help! What could be more productive than teaming up, putting our heads together, and discovering ground-breaking solutions for many complex diseases?

3. Money saved, money earned

The drug development process can be risky, expensive, and not to mention exhausting! A recent study by consulting firm McKinsey & Co. estimated the average cost of bringing a drug to market is $2.6 billion – a 140% increase over the past decade. What’s more, it can take over 10 years for a drug to advance from the preclinical testing phase to notching FDA approval.

Radyus is led by a team of industry veterans, experienced drug developers and venture capitalists, who work closely with new biotech companies like you. Our experts take the guesswork out of preclinical development process and know exactly what it takes to accelerate your timeline to IND, even when you’re on a tight budget. Yes—it can be done!

And that’s the Collaborative Research Organization difference! You work with one dedicated team along the way until we both reach success with your new drug!

Now that’s a different type of CRO!

To start collaborating, please email us at We’re excited to meet you!

Scroll to Top